A series of naphthyridine and naphthyridinone allosteric dual inhibitors of Akt1 and 2 have been developed. These compounds have been optimized to have potent dual activity against the activated kinase as well as the activation of Akt in cells. One molecule in particular, compound 17, has potent inhibitory activity against Akt1 and 2 in vivo in a mouse lung and efficacy in a tumor xenograft model.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2008.04.074 | DOI Listing |
Publication Analysis
Top Keywords
inhibitors akt1
8
tumor xenograft
8
xenograft model
8
allosteric inhibitors
4
akt1 akt2
4
akt2 naphthyridinone
4
naphthyridinone efficacy
4
efficacy a2780
4
a2780 tumor
4
model series
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!